Skip to main content



remedē® System

The remedē System is a breakthrough implantable system that safely and effectively treats moderate to severe Central Sleep Apnea (CSA) in adult patients.1 CSA is a serious breathing disorder that disrupts the normal breathing pattern during sleep and has been shown to negatively impact quality of life and heart health.2

The latest advancement in remedē System technology is now FDA approved.

How it Works

The remedē System is an implantable system that stimulates a nerve in the chest (phrenic nerve) to send signals to the large muscle that controls breathing (the diaphragm). These signals stimulate breathing in the same way that the brain signals breathing.

The remedē System is placed during a minimally invasive outpatient procedure by a cardiologist. The system is a battery powered device placed under the skin in the upper chest area with two small thin wires (leads), one to deliver the therapy (stimulation lead) and one to sense breathing (sensing lead).

The remedē System works to continuously and automatically monitor and stabilize the breathing pattern, restoring sleep throughout the night.

Clinically Proven

In a clinical study, the remedē System has been shown to significantly reduce the effects of CSA:

95% of patient reported they would “elect to have the medical procedure again”2

78% of patients reported quality of life improvement using the Patient Global Assessment2

96 percent pie chart

96% reduction in the median Central Apnea Index at 1 year3

5 years

Improvements in sleep
disordered breathing
and quality sustained
out to 5 years3

Commonly Asked Questions